Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis

Molecular Cancer Research

Volumn 1, Issue 9, 2003, Pages 682-689

  Nonn, Larisa ^a   Berggren, Margareta ^a   Powis, Garth ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GENE PRODUCT; HYDROGEN PEROXIDE; IMEXON; PEROXIREDOXIN 3; TERT BUTYL HYDROPEROXIDE; THIOREDOXIN PEROXIDASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL HYPOXIA; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; MITOCHONDRION; MOUSE; NONHUMAN; PRDX3 GENE; PRIORITY JOURNAL; PROTEIN FAMILY; THYMOMA;

ANIMALS; ANOXIA; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HYDROGEN PEROXIDE; INHIBITORY CONCENTRATION 50; MICE; OXIDATION-REDUCTION; PEROXIDASES; THYMOMA;

ANIMALIA;

EID: 0037827160     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Boveris, A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol., 105: 429-435, 1984.
2. Melov, A. Mitochondrial oxidative stress: physiologic consequences and potential for a role in aging. Ann. NY Acad. Sci., 908: 219-225, 2000.
3. Simon, H. U., Yehia-Haj, A., and Levi-Schaffer, F. Role of reactive oxygen species (ROS) in apoptosis function. Apoptosis, 5: 415-418, 2000.
4. Huang, R. P., Wu, J. X., Fan, Y., and Adamson, E. D. UV activates growth factor receptors via reactive oxygen species. J. Cell Biol., 133: 211-220, 1996.
5. Zoratti, M. and Szabo, I. The mitochondrial permeability transition. Biochim. Biophys. Acta, 1241: 139-176, 1995.
6. Lui, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86: 147-157, 1996.
7. Susin, S. A., Zamzami, N., Castedo, M., Hiersch, T., Marchetti, P., Macho, A., Daugas, E., Geuskens, M., and Kroemer, G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184: 1331-1341, 1996.
8. Nicholls, D. G. Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int. J. Biochem. Cell Biol., 34: 1372-1381, 2002.
9. Di Lisa, F. Mitochondrial contribution in the progression of cardiac ischemic injury. IUBMB Life, 52: 255-261, 2001.
10. Dhalla, N. S., Temsah, R. M., and Netticadan, T. Role of oxidative stress in cardiovascular disease. J. Hypertens., 18: 655-673, 2000.
11. Radi, R., Turrens, J. F., Change, L. Y., Bush, K. M., Crapo, J. D., and Freeman, B. A. Detection of catalase in rat heart mitochondria. J. Biol. Chem., 266: 22028-22034, 2001.
12. Knopp, E. A., Amdt, T. L., Eng, K. L., Caldwell, M., Leboef, R. C., Deeb, S. S., and O'Brien, K. D. Murine phospholipids hydroperoxide glutathione peroxidase: cDNA sequence, tissue expression and mapping. Mamm. Genome, 10: 601-605, 1999.
13. Chae, H. Z., Kim, H. J., Kang, S. W., and Rhee, S. G. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res. Clin. Pract., 45: 101-112, 1999.
14. Kang, S. W., Chae, H. Z., Seo, M. S., Kim, K., Baines, I. C., and Rhee, S. G. Mammalian peroxidoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem., 273: 6297-6302, 1998.
15. Lim, Y. S., Cha, M. K., Yun, C. H., Kim, H. K., Kim, K., and Kim, I. H. Purification and characterization of thiol-specific antioxidant protein from human red blood cell: a new type of antioxidant protein. Biochem. Biophys. Res. Commun., 199: 199-206, 1994.
16. 2 mixed-function oxidation system. J. Biol. Chem., 263: 4704-4711, 1988.
17. Fisher, A. B., Dodia, C., Manevich, Y., Chen, J. W., and Feinstein, S. I. Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J. Biol. Chem., 274: 21326-21334, 1999.
18. Singh, A. K. and Shichi, H. A novel glutathione peroxidase in bovine eye. Sequence analysis, mRNA level and translation. J. Biol. Chem., 273: 26171-26178, 1998.
19. Kinnula, V. L., Lehtonen, S., Sormunen, R., Kaarteenaho-Wiik, R., Kang, S. W., Rhee, S. G., and Soini, Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J. Pathol., 196: 316-323, 2002.
20. Mizusawa, H., Ishii, T., and Bannai, S. Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci. Lett., 283: 57-60, 2000.
21. Oberley, T. D., Verwiebe, E., Zhong, W., Kang, S. W., and Rhee, S. G. Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med., 30: 412-424, 2001.
22. Watabe, S., Hiroi, T., Yamamoto, Y., Fujioka, Y., Hasegawa, H., Yago, N., and Takahashi, S. Y. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur. J. Biochem., 249: 52-60, 1997.
23. Okado-Matsumoto, A., Matsumoto, A., Fujii, J., and Taniguchi, N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J. Biochem., 127: 493-501, 2000.
24. Seo, M. S., Kang, S. W., Kim, K., Baines, I. C., Lee, T. H., and Rhee, S. G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biochem., 275: 20346-20354, 2000.
25. Yanagawa, T., Iwasa, S., Ishii, T., Tabuchi, K., Iwasa, S., Bannai, S., Omura, K., Suzuki, H., and Yoshida, H. Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett., 156: 27-35, 2000.
26. Yanagawa, T., Iwasa, S., Ishii, T., Tabuchi, K., Yusa, H., Onizawa, K., Omura, K., Suzuki, H., and Yoshida, H. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett., 145: 127-132, 1999.
27. Noh, D. Y., Ahn, S. J., Lee, R. A., Kim, S. W., Park, I. A., and Chae, H. Z. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res., 21: 2085-2090, 2001.
28. Chang, J. W., Jeon, H. B., Lee, J. H., Yoo, J. S., Chun, J. S., Kim, J. H., and Yoo, Y. J. Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Commun., 289: 507-512, 2001.
29. Yamamoto, Y., Mantsui, Y., Natori, S., and Obinata, M. Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Oncogene, 80: 337-343, 1989.
30. Araki, M., Nanri, H., Ejima, K., Murasato, Y., Fujiwara, T., Nakashima, Y., and Ikeda, M. Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J. Biol. Chem., 274: 2271-2278, 1999.
31. Wonsey, D. R., Zeller, K. I., and Dang, C. V. The c-myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc. Natl. Acad. Sci. USA, 99: 6649-6654, 2002.
32. Briehl, M. M., Cotgreave, I. A., and Powis, G. Downregulation of the antioxidant defense during glucocorticoid-mediated apoptosis. Cell Death Differ., 2: 41-46, 1995.
33. Freemerman, A. J. and Powis, G. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells. Biochem. Biophys. Res. Commun., 274: 136-141, 2000.
34. Briehl, M., Tome, M. E., Baker, A. F., Powis, G., and Payne, C. M. Catalase-overexpressing thymocytes are resistant to steroid-induced apoptosis and exhibit increased net tumor growth. Am. Assoc. Cancer Res., 41: 828, 2000.
35. 2 sensing. J. Biol. Chem., 275: 25130-25138, 2000.
36. Dvorakova, K., Waltmire, C. N., Payne, C. M., Tome, M. E., Briehl, M. M., and Dorr, R. T. Induction of mitochondrial changes in myeloma cells by imexon. Blood, 11: 3544-3551, 2001.
37. Rhee, S. G., Bae, Y. S., Lee, S. R., and Kwon, J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Signal Transduct. Knowl. Environ., 53: 1-6, 2000.
38. 2 for platelet-derived growth factor signal transduction. Science, 270: 296-299, 1995.
39. Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 275: 1649-1652, 1997.
40. Gallegos, A., Gasdaska, J. R., Taylor, C. W., Paine-Murrieta, G. D., Goodman, D., Gasdaska, P. Y., Berggren, M., Briehl, M. M., and Powis, G. Transfection with human thioredoxin increases cell proliferation and a dominant negative mutant thioredoxin reverses the transformed phenotype of breast cancer cells. Cancer Res., 56: 5765-5770, 1996.
41. Takeyama, N., Miki, S., Hirakawa, A., and Tanaka, T. Role of mitochondrial permeability transition and cytochrome c release in hydrogen peroxide-induced apoptosis. Exp. Cell Res., 274: 16-24, 2002.
42. Cidlowski, J. A. and Scwartzman, R. A. Glucocorticoid-induced apoptosis of lymphoid cells. Int. Arch. Allergy Appl. Immunol., 105(4): 347-354, 1994.
43. Renner, K., Kofler, R., and Gnaiger, E. Mitochondrial function in glucocorticoid triggered T-ALL cells with transgenic bcl-2 expression. Mol. Biol. Rep. 29(1-2): 97-101, 2002.
44. Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., and Schumacker, P. T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA, 95: 15-10, 1998.
45. Richard, D. E., Berra, E., and Pouyssegur, J. Angiogenesis: How a tumor adapts to hypoxia. Biochem. Biophys. Res. Commun., 266: 718-722, 1999.
46. Nonn, L., Williams, R.R., Erickson, R. P., and Powis, G. Absence of mitochondrial thioredoxin-2 causes apoptosis, exencephaly and embryonic lethality in homozygous mice. Mol. Cell. Biol., 23: 916-922, 2003.
47. Oblong, J. E., Gasdaska, P. Y., Sherrill, K., and Powis, G. Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy. Biochemistry, 32: 7271-7277, 1993.
48. Eposti, M. Measuring mitochondrial reactive oxygen species. Methods Enzymol., 26: 335-340, 2002.